Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents with Congenital Adrenal Hyperplasia.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM（2023）
Key words
congenital adrenal hyperplasia,21-hydroxylase deficiency,crinecerfont,CRF type 1 receptor antagonist,adolescents,pediatric
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined